Where does Lensar, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lensar, Inc. ranks #5,855 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lensar, Inc. hold?

Lensar, Inc. holds 58 US utility patents granted between 2015 and 2025, spanning 15 technology areas.

What is Lensar, Inc.'s Innovation Score?

Lensar, Inc. has an Innovation Score of 47.8 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Lensar, Inc.'s patent grant rate increasing or decreasing?

Lensar, Inc.'s recent grant velocity is +177% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Lensar, Inc.'s patents?

Lensar, Inc.'s patents average 17.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lensar, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Lensar, Inc.

Q: What technology areas does Lensar, Inc. focus on?

Lensar, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 44 patents, ranking #140 of 3,082 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

USPTO PatentsView assignee record - 58 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lensar ranks #5,855 of 49,997 tracked US assignees by granted-patent volume, with 58 patents across 15 technology areas.

#5,855
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.8/100): 17.4
avg claims per patent: +177%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5855 · US Corporation #5,855 · 58 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 58 grants
UPPER-Q #5,855/49,997
PHOTO-FINISH Leapfrog Product…
CPC-FOCUS A61F · 15 areas
INNOV-PAR 47.8/100
CLAIMS-RICH 17.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +177% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Leapfrog Product Development LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lensar’s 47.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.1 pts (29%) Velocity 9.6 pts (20%) Breadth 13.7 pts (29%) Claim depth 10.4 pts (22%)

Qualcomm Incorporated · highest

85
Ancestry com DNA · near

48
Invensys Systems · near

48
Lensar · this assignee

48
Luminous Computing · near

48
Zonit Structured… · near

48
3D Lighting… · lowest

7

What this shows Lensar's Innovation Score is 47.8/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Lensar?

Each dot is one of Lensar’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lensar’s own 17.4 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Lensar vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lensar's grants concentrate

Lensar, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 75.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (13 grants) versus a trough of 1 in 2015. By volume, Lensar sits between L'ORÉAL and Mattersight Corporation.

Lensar's three-year grant acceleration

Lensar, Inc. shows 23 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

L'orÉAL

58
Lisi Aerospace

58
Lutronic

58
Leapfrog Product…

58
MAC Trailer Manuf…

58
MAG Instrument

58
Mastercard ASIA/P…

58
Mattersight

58
Lensar ◀

58

What this shows Lensar holds 58 patents at rank #5,858, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lensar

By rank, the assignees closest to #5,858 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Lensar's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Lensar, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Lensar ranks #140 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (48 here).

Zonit Structured Solutions, LLC 48 Invensys Systems, Inc. 48 Luminous Computing, Inc. 48 Ancestry.com DNA, LLC 48

Similar claim depth

Nearest assignees by average claims per patent (17.4 here).

Largan Digital Co., Ltd. 17.4 avg EBERSPÄCHER Climate Control Systems GMBH 17.4 avg Electronic Theatre Controls, Inc. 17.4 avg Technische Universität Wien 17.4 avg

Lensar's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Lensar, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	1.7%
2016	2	3.4%
2017	3	5.2%
2018	4	6.9%
2019	3	5.2%
2020	5	8.6%
2021	8	13.8%
2022	4	6.9%
2023	13	22.4%
2024	6	10.3%
2025partial year	9	15.5%

Which technologies does Lensar, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 44

A61B - DIAGNOSIS; SURGERY; Identification 28

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G02B - Optical Elements, Systems OR Apparatus 2

H04N - Pictorial Communication, e.g. Television 2

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 1

C04B - Lime, MAGNESIA; SLAG; CEMENTS; Compositions Thereof, e.g. Mortars, Concrete OR Like Building MATERIALS; Artificial Stone ; Ceramics ; REFRACTORIES; Treatment OF Natural Stone 1

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 1

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

C01B - Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c 1

C08L - Compositions OF Macromolecular Compounds 1

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Lensar, Inc.'s patent record in context - here's where to go next.

Lensar, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 75.9% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #5,855 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lensar, Inc. against L'ORÉAL, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.